Home › Migraine › Michigan › Ann Arbor
Migraine clinical trials in Ann Arbor, MI
5 studies for Migraine are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Michigan Head Pain and Neurological Institute, Ann Arbor
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Michigan Head Pain & Neurological Institute, Ann Arbor
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
RecruitingPhase 3
- Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
Study of EVO756 in Adults With Migraine
RecruitingPhase 2
- Michigan Headache and Neurological Institute, Ann Arbor
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RecruitingPhase 3
- Michigan Headache Pain & Neurological Institute, Ann Arbor
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Concord, CA8 studies
- Philadelphia, PA8 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Washington, DC7 studies
- Houston, TX7 studies
- Omaha, NE7 studies
- Amherst, NY7 studies
- Tampa, FL6 studies
- Charlotte, NC6 studies
- Orlando, FL6 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.